30.01.2013 Views

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Poster<br />

Topic: General Orthopaedics<br />

Abstract number: 25847<br />

THE DIAGNOSTIC UTILITY AND COST EFFECTIVENESS OF USING A<br />

HANDHELD CARPAL TUNNEL SYNDROME TESTING DEVICE AT A SMALL<br />

DISTRICT GENERAL HOSPITAL<br />

Daniel HARLE, Peter KENYON, Jochen FISCHER<br />

Macclesfeld District General Hospital, Cheshire (UNITED KINGDOM)<br />

Objective: The diagnostic utility and cost effectiveness of the Mediracer handheld<br />

carpal tunnel syndrome (CTS) tester used at a small district general hospital were<br />

evaluated. METHOD: Using the test device, the sensory nerve conductions in the<br />

median nerve were tested in 23 patients presenting with symptoms of CTS over a<br />

two month period. Data were analysed to determine the diagnostic utility of the<br />

device and to determine the cost effectiveness of using the device compared to that<br />

of using more formal nerve conduction studies for CTS. RESULTS: 30 tests were<br />

performed lasting approximately 25 minutes. All tests were performed to confirm or<br />

refute a diagnosis of CTS. All patients would have been referred for formal nerve<br />

conduction studies otherwise. We were unable to obtain readings on 3 patients. 4 of<br />

23 patients were referred for further nerve conduction studies with only 2 because<br />

the device did not work. Total cost of Mediracer tests including the cost of 4 formal<br />

nerve conduction studies was 1370 pounds. Total cost of the formal nerve<br />

conductions studies what would have been required if the Mediracer device was not<br />

used would have been 5100 pounds. Total savings of using the Mediracer CTS<br />

device was 3730 pounds. Conclusion: The findings obtained with the Mediracer CTS<br />

device were reliable and reproducible. The cost effectiveness of using the devise<br />

compared to that of formal CTS tests was significant, with potential annual savings at<br />

a small district general hospital between 15,000 to 20,000 pounds.<br />

262

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!